Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (NASDAQ:TPIV)

4.78
Delayed Data
As of 3:07pm ET
 +0.4799 / +11.16%
Today’s Change
3.32
Today|||52-Week Range
9.83
+23.19%
Year-to-Date
No recent news for TapImmune Inc.

Today’s Trading

Previous close4.30
Today’s open4.25
Day’s range4.25 - 4.97
Volume196,125
Average volume (3 months)30,507
Market cap$36.1M
Dividend yield--
Data as of 3:07pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+61.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio6.7
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RTTRRitter Pharmaceutica...+0.11+3.40%
XBIOXenetic Biosciences ...0.000.00%
EYEGEyeGate Pharmaceutic...-1.00-27.03%
CERUCerulean Pharma Inc-0.10-7.17%
Data as of 3:08pm ET, 02/22/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$34.1M
Net profit margin--

Profile

Sector
Consumer Services
Industry
Other Consumer Services
Chairman, CEO, Secretary &
CAO
Glynn Wilson
President, Chief Operating Officer &
Director
John N. Bonfiglio
Corporate headquarters
Jacksonville, Florida

Forecasts


Search for Jobs